epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove ibandronate
    generic
  • remove Pepto-Bismol LiquiCaps
    bismuth subsalicylate

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face ibandronate (generic) + Pepto-Bismol LiquiCaps (bismuth subsalicylate)

Monitor/Modify Tx


ibandronate + bismuth subsalicylate

monitor bleeding signs/symptoms if oral ibandronate use: combo may incr. risk of upper GI ulceration, perforation, bleeding (additive effects)

Additional Considerations

Smiley face Smiley face ibandronate

administer oral ibandronate at least 1h before other oral drugs; combo may decr. ibandronate absorption, efficacy

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information